H-Gly-DL-Ala-DL-Val-DL-Ser-Gly-DL-Leu-DL-Leu-DL-xiThr-DL-Asn-DL-Leu-Gly-DL-Leu-OH
| Internal ID | 97c1ac4a-d553-4ea8-85c3-25c10982b1bc |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides |
| IUPAC Name | 2-[[2-[[2-[[4-amino-2-[[2-[[2-[[2-[[2-[[2-[[2-[2-[(2-aminoacetyl)amino]propanoylamino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-4-methylpentanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C49H87N13O16/c1-22(2)13-29(42(70)52-20-38(68)56-33(49(77)78)16-25(7)8)57-45(73)32(17-35(51)65)59-48(76)40(28(12)64)62-46(74)31(15-24(5)6)58-44(72)30(14-23(3)4)55-37(67)19-53-43(71)34(21-63)60-47(75)39(26(9)10)61-41(69)27(11)54-36(66)18-50/h22-34,39-40,63-64H,13-21,50H2,1-12H3,(H2,51,65)(H,52,70)(H,53,71)(H,54,66)(H,55,67)(H,56,68)(H,57,73)(H,58,72)(H,59,76)(H,60,75)(H,61,69)(H,62,74)(H,77,78) |
| InChI Key | AVNHJRDZHLHVSN-UHFFFAOYSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C49H87N13O16 |
| Molecular Weight | 1114.30 g/mol |
| Exact Mass | 1113.63937374 g/mol |
| Topological Polar Surface Area (TPSA) | 467.00 Ų |
| XlogP | -3.90 |
| Atomic LogP (AlogP) | -5.27 |
| H-Bond Acceptor | 16 |
| H-Bond Donor | 16 |
| Rotatable Bonds | 36 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.4664 | 46.64% |
| Caco-2 | - | 0.8607 | 86.07% |
| Blood Brain Barrier | + | 0.6000 | 60.00% |
| Human oral bioavailability | - | 0.6714 | 67.14% |
| Subcellular localzation | Mitochondria | 0.5447 | 54.47% |
| OATP2B1 inhibitior | - | 0.7221 | 72.21% |
| OATP1B1 inhibitior | + | 0.8691 | 86.91% |
| OATP1B3 inhibitior | + | 0.9225 | 92.25% |
| MATE1 inhibitior | - | 0.9800 | 98.00% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | + | 0.9005 | 90.05% |
| P-glycoprotein inhibitior | + | 0.7391 | 73.91% |
| P-glycoprotein substrate | + | 0.7523 | 75.23% |
| CYP3A4 substrate | + | 0.6340 | 63.40% |
| CYP2C9 substrate | - | 0.5981 | 59.81% |
| CYP2D6 substrate | - | 0.8230 | 82.30% |
| CYP3A4 inhibition | - | 0.8883 | 88.83% |
| CYP2C9 inhibition | - | 0.8996 | 89.96% |
| CYP2C19 inhibition | - | 0.8638 | 86.38% |
| CYP2D6 inhibition | - | 0.9240 | 92.40% |
| CYP1A2 inhibition | - | 0.9123 | 91.23% |
| CYP2C8 inhibition | - | 0.6713 | 67.13% |
| CYP inhibitory promiscuity | - | 0.9704 | 97.04% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8700 | 87.00% |
| Carcinogenicity (trinary) | Non-required | 0.6409 | 64.09% |
| Eye corrosion | - | 0.9724 | 97.24% |
| Eye irritation | - | 0.8967 | 89.67% |
| Skin irritation | - | 0.8430 | 84.30% |
| Skin corrosion | - | 0.9577 | 95.77% |
| Ames mutagenesis | - | 0.6600 | 66.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6682 | 66.82% |
| Micronuclear | + | 0.5600 | 56.00% |
| Hepatotoxicity | - | 0.5093 | 50.93% |
| skin sensitisation | - | 0.9055 | 90.55% |
| Respiratory toxicity | + | 0.6333 | 63.33% |
| Reproductive toxicity | - | 0.6053 | 60.53% |
| Mitochondrial toxicity | - | 0.5750 | 57.50% |
| Nephrotoxicity | - | 0.7106 | 71.06% |
| Acute Oral Toxicity (c) | III | 0.6451 | 64.51% |
| Estrogen receptor binding | + | 0.7559 | 75.59% |
| Androgen receptor binding | + | 0.6890 | 68.90% |
| Thyroid receptor binding | + | 0.5408 | 54.08% |
| Glucocorticoid receptor binding | + | 0.5659 | 56.59% |
| Aromatase binding | + | 0.6876 | 68.76% |
| PPAR gamma | + | 0.7354 | 73.54% |
| Honey bee toxicity | - | 0.8523 | 85.23% |
| Biodegradation | - | 0.7500 | 75.00% |
| Crustacea aquatic toxicity | - | 0.8000 | 80.00% |
| Fish aquatic toxicity | - | 0.8191 | 81.91% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.51% | 98.95% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.29% | 83.82% |
| CHEMBL236 | P41143 | Delta opioid receptor | 99.06% | 99.35% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 98.52% | 89.63% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 97.96% | 90.17% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 97.38% | 98.94% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 97.31% | 97.23% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 97.23% | 98.89% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 97.18% | 100.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 95.45% | 93.56% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 95.08% | 88.42% |
| CHEMBL3837 | P07711 | Cathepsin L | 94.84% | 96.61% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 94.82% | 92.80% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 93.95% | 96.09% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 93.73% | 90.20% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 93.58% | 96.00% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 93.40% | 98.05% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 93.30% | 96.47% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 93.28% | 91.11% |
| CHEMBL3286 | P00749 | Urokinase-type plasminogen activator | 93.15% | 97.88% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 92.57% | 99.17% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 92.01% | 97.21% |
| CHEMBL3308 | P55212 | Caspase-6 | 91.22% | 97.56% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 91.01% | 89.50% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 90.33% | 100.00% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 90.32% | 89.33% |
| CHEMBL3776 | Q14790 | Caspase-8 | 90.29% | 97.06% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 90.11% | 96.95% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 89.68% | 94.45% |
| CHEMBL1907589 | P17787 | Neuronal acetylcholine receptor; alpha4/beta2 | 89.16% | 94.55% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 88.85% | 92.29% |
| CHEMBL1981 | P06213 | Insulin receptor | 88.78% | 97.37% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 88.49% | 94.00% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 88.31% | 96.67% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 87.54% | 95.71% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 86.10% | 96.28% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 86.00% | 93.00% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 84.81% | 98.33% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 84.57% | 93.10% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 83.97% | 99.77% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 83.88% | 98.10% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 83.66% | 90.71% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 83.00% | 93.33% |
| CHEMBL2885 | P07451 | Carbonic anhydrase III | 82.88% | 87.45% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 82.63% | 95.50% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 82.28% | 97.09% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 80.97% | 91.19% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 80.91% | 100.00% |
| CHEMBL2964 | P36507 | Dual specificity mitogen-activated protein kinase kinase 2 | 80.72% | 80.00% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 80.00% | 95.38% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 163088095 |
| LOTUS | LTS0271674 |
| wikiData | Q104919654 |